There’s Still Time to Buy Coherus Biosciences Inc (NASDAQ:CHRS) Stock
In yesterday’s Wall Street session, Coherus Biosciences Inc (NASDAQ:CHRS) shares traded at $2.30, down -2.95% from the previous session. CHRS stock price is now -15.28% away from the 50-day moving average and -51.44% away from the 200-day moving average. The market capitalization of the company currently stands at $256.13M. With the price target of $11, […]
A Stock With Stellar Fundamentals? Coherus Biosciences Inc (NASDAQ:CHRS): Is It Right For You?
In yesterday’s Wall Street session, Coherus Biosciences Inc (NASDAQ:CHRS) shares traded at $2.18, up 3.32% from the previous session. As of this writing, 9 analysts cover Coherus Biosciences Inc (NASDAQ:CHRS). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $15.00 and a […]
Reasons why Coherus Biosciences Inc’s (NASDAQ:CHRS) fundamentals are futile
In yesterday’s Wall Street session, Coherus Biosciences Inc (NASDAQ:CHRS) shares traded at $2.13, up 24.56% from the previous session. 9 analysts cover Coherus Biosciences Inc (NASDAQ:CHRS), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $15.00 and a […]
Could Coherus Biosciences Inc (CHRS) stock price achieve new all-time highs if its expected earnings and revenue increase?
In yesterday’s Wall Street session, Coherus Biosciences Inc (NASDAQ:CHRS) shares traded at $1.59, down -0.62% from the previous session. As of this writing, 8 analysts cover Coherus Biosciences Inc (NASDAQ:CHRS). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $15.00 and a […]
Reasons why Coherus Biosciences Inc’s (NASDAQ:CHRS) fundamentals are futile
In yesterday’s Wall Street session, Coherus Biosciences Inc (NASDAQ:CHRS) shares traded at $2.47, down -30.23% from the previous session. 9 analysts cover Coherus Biosciences Inc (NASDAQ:CHRS), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $15.00 and a […]
How should investors evaluate Coherus Biosciences Inc (NASDAQ:CHRS)?
Stocks of Coherus Biosciences Inc (NASDAQ:CHRS) traded higher last session on Wall Street, up 14.02% to $3.01. According to the data, Coherus Biosciences Inc (NASDAQ:CHRS) has 9 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. CHRS stock price is now -28.01% away from the 50-day moving average and -47.18% away from the […]
Can Coherus BioSciences Inc. (CHRS) stock recover despite sales dropping?
In yesterday’s Wall Street session, Coherus BioSciences Inc. (NASDAQ:CHRS) shares traded at $4.14, down -8.20% from the previous session. 9 analysts cover Coherus BioSciences Inc. (NASDAQ:CHRS), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $20.00 and a […]
There is little time left for Coherus BioSciences Inc. (CHRS) to reach its 1-year target estimate. How soon will it surpass it?
Coherus BioSciences Inc. (NASDAQ:CHRS) shares traded -7.14% lower at $4.68 on Wall Street last session. In accordance with the data, 9 analysts cover Coherus BioSciences Inc. (NASDAQ:CHRS). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $20.00 and a low of $7.00, […]
Despite Coherus BioSciences Inc. [CHRS]’s great opportunity, the stock is a bit overvalued
The price of Coherus BioSciences Inc. (NASDAQ:CHRS) shares last traded on Wall Street rose 0.45% to $4.42. CHRS stock price is now -3.04% away from the 50-day moving average and -35.92% away from the 200-day moving average. The market capitalization of the company currently stands at $405.71M. With the price target of $12, Citigroup recently […]